Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
INDV Indivior Plc
- Stocks
- Healthcare
- NASDAQ: INDV
Price (delayed)
$11.34
Market cap
$1.41B
P/E Ratio
189
Dividend/share
N/A
EPS
$0.06
Enterprise value
$1.41B
Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders. The company's product pipeline
Highlights
The EPS has soared by 200% from the previous quarter and by 107% YoY
The net income has surged by 103% year-on-year and by 50% since the previous quarter
Indivior's debt has increased by 33% YoY
The quick ratio has contracted by 9% YoY
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Website: https://www.indivior.com
Key stats
What are the main financial stats of INDV
Market
Valuations
Earnings
Shares outstanding
124.77M
Market cap
$1.41B
Enterprise value
$1.41B
Price to earnings (P/E)
189
Price to book (P/B)
N/A
Price to sales (P/S)
1.2
EV/EBIT
26.66
EV/EBITDA
18.11
EV/Sales
1.21
Revenue
$1.17B
Gross profit
$942M
Operating income
$35M
Net income
$3M
EBIT
$53M
EBITDA
$78M
Free cash flow
$104M
Per share
Balance sheet
Liquidity
EPS
$0.06
EPS diluted
$0.06
Free cash flow per share
$0.84
Book value per share
-$2.29
Revenue per share
$9.44
TBVPS
$11.03
Total assets
$1.38B
Total liabilities
$1.66B
Debt
$370M
Equity
-$285M
Working capital
-$122M
Debt to equity
-1.3
Current ratio
0.88
Quick ratio
0.61
Net debt/EBITDA
-0.03
Margins
Efficiency
Dividend
EBITDA margin
6.7%
Gross margin
80.4%
Net margin
0.3%
Operating margin
3%
Return on assets
0.2%
Return on equity
N/A
Return on invested capital
15.2%
Return on capital employed
14.3%
Return on sales
4.5%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
INDV stock price
How has the Indivior stock price performed over time
Intraday
2.44%
1 week
2.35%
1 month
25.17%
1 year
-34.6%
YTD
-8.77%
QTD
18.99%
Financial performance
How have Indivior's revenue and profit performed over time
Revenue
$1.17B
Gross profit
$942M
Operating income
$35M
Net income
$3M
Gross margin
80.4%
Net margin
0.3%
The operating income has surged by 125% year-on-year and by 9% since the previous quarter
INDV's operating margin has surged by 124% year-on-year and by 11% since the previous quarter
Indivior's net margin has soared by 103% YoY and by 50% from the previous quarter
The net income has surged by 103% year-on-year and by 50% since the previous quarter
Price vs fundamentals
How does INDV's price correlate with its fundamentals
Growth
What is Indivior's growth rate over time
Valuation
What is Indivior stock price valuation
P/E
189
P/B
N/A
P/S
1.2
EV/EBIT
26.66
EV/EBITDA
18.11
EV/Sales
1.21
The EPS has soared by 200% from the previous quarter and by 107% YoY
The equity has grown by 15% from the previous quarter
The stock's price to sales (P/S) is 14% less than its last 4 quarters average of 1.4
INDV's revenue is up by 4.2% year-on-year
Efficiency
How efficient is Indivior business performance
The ROS has soared by 151% YoY
Indivior's return on invested capital has surged by 143% YoY
Indivior's ROA has soared by 103% YoY and by 100% from the previous quarter
Dividends
What is INDV's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for INDV.
Financial health
How did Indivior financials performed over time
Indivior's total assets is 17% lower than its total liabilities
INDV's total liabilities is up by 15% year-on-year
The quick ratio has contracted by 9% YoY
The debt to equity has dropped by 105% year-on-year and by 17% since the previous quarter
Indivior's debt has increased by 33% YoY
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.